Patents by Inventor Chengting Zi

Chengting Zi has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20220211662
    Abstract: Disclosed is an application of Epigallocatechin Gallate (EGCG) or a compound synthesized with it as a lead compound in combination with one or more tyrosine kinase inhibitors in preparation of a cancer treatment drug, herein the cancer is an Epidermal Growth Factor Receptor (EGFR) wild-type tumor. This combined use may significantly inhibit the growth of the EGFR wild-type tumor, and reduce the toxic and side effects of an anticancer drug.
    Type: Application
    Filed: May 7, 2019
    Publication date: July 7, 2022
    Inventors: Jun Sheng, Xuanjun Wang, Yanping Huang, Chengting Zi, Zemin Xiang, Yewei Huang, Yunli Zhao, Xiangdan Cuan, Huanhuan Xu, Rui Luo